Literature DB >> 25274450

The Clinical Features of Sarcoidosis: A Comprehensive Review.

Marc A Judson1.   

Abstract

Sarcoidosis has innumerable clinical manifestations, as the disease may affect every body organ. Furthermore, the severity of sarcoidosis involvement may range from an asymptomatic state to a life-threatening condition. This manuscript reviews a wide variety of common and less common clinical characteristics of sarcoidosis. These manifestations are presented organ by organ, although additional sections describe systemic and multiorgan presentations of sarcoidosis. The lung is the organ most commonly involved with sarcoidosis with at least 90 % of sarcoidosis patients demonstrating lung involvement in most series. The skin, eye, liver, and peripheral lymph node are the next most commonly clinically involved organs in most series, with the frequency of involvement ranging from 10 to 30 %. The actual frequency of sarcoidosis organ involvement is probably much higher as it is frequently asymptomatic and may avoid detection. This is particularly common with lung, liver, cardiac, and bone involvement. Cardiac sarcoidosis is present in 25 % of all sarcoidosis but only causes clinical problems in 5 % of them. Nevertheless, unlike sarcoidosis involvement of most other organs, it may be suddenly fatal. Therefore, it is important to screen for cardiac sarcoidosis in all sarcoidosis patients. All sarcoidosis patients should also be screened for eye involvement as asymptomatic patients may have eye involvement that may cause permanent vision impairment. Pulmonary fibrosis from sarcoidosis is usually slowly progressive but may be life-threatening because of the development of respiratory failure, pulmonary hypertension, or hemoptysis related to a mycetoma or bronchiectasis. Some manifestations of sarcoidosis are not organ-specific and probably are the result of a release of mediators from the sarcoid granuloma. Two such manifestations include small fiber neuropathy and fatigue syndromes, and they are observed in a large percentage of patients.

Entities:  

Mesh:

Year:  2015        PMID: 25274450     DOI: 10.1007/s12016-014-8450-y

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  227 in total

Review 1.  Ulcerative sarcoidosis: case report and review of the Japanese literature.

Authors:  Yoshiro Ichiki; Yasuo Kitajima
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

Review 2.  Myocardial sarcoidosis.

Authors:  O P Sharma; A Maheshwari; K Thaker
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

3.  Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis.

Authors:  P W Boros; P L Enright; P H Quanjer; G J J M Borsboom; S P Wesolowski; R E Hyatt
Journal:  Eur Respir J       Date:  2010-04-08       Impact factor: 16.671

4.  Sarcoidosis presenting as spiculated breast masses.

Authors:  J J Gisvold; T B Crotty; R E Johnson
Journal:  Mayo Clin Proc       Date:  2000-03       Impact factor: 7.616

5.  Predicting mortality in patients with sarcoidosis awaiting lung transplantation.

Authors:  Andrew F Shorr; Darcy B Davies; Steven D Nathan
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

6.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Obstructive hydrocephalus and progressive psychosis: rare presentations of neurosarcoidosis.

Authors:  Franklin D Westhout; Mark E Linskey
Journal:  Surg Neurol       Date:  2007-10-31

8.  Clinicopathologic features of ulcerative-atrophic sarcoidosis.

Authors:  Simon S Yoo; Daniel Mimouni; Olga V Nikolskaia; David J Kouba; Daniel N Sauder; Carlos H Nousari
Journal:  Int J Dermatol       Date:  2004-02       Impact factor: 2.736

9.  Intraepidermal nerve fiber density and its application in sarcoidosis.

Authors:  M Bakkers; I S J Merkies; G Lauria; G Devigili; P Penza; R Lombardi; M C E Hermans; S I van Nes; M De Baets; C G Faber
Journal:  Neurology       Date:  2009-10-06       Impact factor: 9.910

10.  The prevalence of sacroiliitis and spondyloarthritis in patients with sarcoidosis.

Authors:  Senol Kobak; Fidan Sever; Ozlem Ince; Mehmet Orman
Journal:  Int J Rheumatol       Date:  2014-05-12
View more
  37 in total

1.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  Highlights from the 2018 European Respiratory Society Congress presentations on interstitial lung diseases.

Authors:  Tiago M Alfaro; Margarida Afonso; Sebastiano Emanuele Torrisi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Shared αβ TCR Usage in Lungs of Sarcoidosis Patients with Löfgren's Syndrome.

Authors:  Angela M Mitchell; Ylva Kaiser; Michael T Falta; Daniel J Munson; Laurie G Landry; Anders Eklund; Maki Nakayama; Jill E Slansky; Johan Grunewald; Andrew P Fontenot
Journal:  J Immunol       Date:  2017-08-21       Impact factor: 5.422

Review 4.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

Review 5.  Nasoseptal Perforation: from Etiology to Treatment.

Authors:  Carla Pereira; Alfonso Santamaría; Cristobal Langdon; Mauricio López-Chacón; José Hernández-Rodríguez; Isam Alobid
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-05       Impact factor: 4.806

6.  Neutrophils and the S100A9 protein critically regulate granuloma formation.

Authors:  Yuya Yoshioka; Tatsuaki Mizutani; Satoshi Mizuta; Ayumi Miyamoto; Satoru Murata; Toshiaki Ano; Hiroshi Ichise; Daisuke Morita; Hiroyuki Yamada; Yoshihiko Hoshino; Tatsuaki Tsuruyama; Masahiko Sugita
Journal:  Blood Adv       Date:  2016-12-14

7.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 8.  The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis.

Authors:  Antje Prasse
Journal:  Dtsch Arztebl Int       Date:  2016-08-22       Impact factor: 5.594

9.  Measuring activity in patients with sarcoidosis - a pilot trial of two wrist-worn accelerometer devices.

Authors:  Christopher P Atkins; Andy P Jones; Andrew M Wilson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

10.  A rare manifestation of a multisystemic disease: a case of vocal cord palsy secondary to sarcoidosis.

Authors:  Saleem Mastan; Rajeev Advani; Nicola Stobbs; Nirmal Kumar
Journal:  BMJ Case Rep       Date:  2015-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.